Study to identify biomarkers predicting progression from non-severe to severe COVD 19 cases

Study to identify biomarkers predicting progression from non-severe to severe COVD 19 cases

Question: Which of the following statutory body will support the exploration of metabolomics alteration in COVID-19 infected patients conducted by IIT Bombay?
(a) Science and Engineering Research Board (SERB)
(b) King George Medical College
(c) National Institute of Virology
(d) Indian Institute of Science
Answer: (a)
Related facts:

  • The Science and Engineering Research Board (SERB), a statutory body under the Department of Science and Technology (DST), will support the exploration of metabolomics alteration in COVID-19 infected patients.
  • This will be conducted by IIT Bombay in collaboration with some hospitals in Mumbai.
  • The study:
  • The study will identify potential biomarker candidates to predict progression from non-severe to severe COVID-19 conditions.
  • Search for potential diagnostic candidates will involve metabolite profiling of different patient groups with various complications.
  • Metabolites are small biomolecules, capable of regulating various pathways in all the living-organisms.
  • A team of over 20 researchers having expertise in handling a large number of different types of human biospecimens will work on it.
  • Investigation of different patient groups having mild to severe symptoms will provide early cues to identify an asymptomatic group of patients and the difference between severe cases of COVID-19 from non-severe ones.

Author: Himanshu Shukla

Links:
https://www.pib.gov.in/PressReleasePage.aspx?PRID=1614815